Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer

This study has been completed.

Study NCT00281866 Information provided by National Cancer Institute (NCI)

First Received: January 24, 2006 Last Updated: May 23, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given